HCA Healthcare (NYSE:HCA) had its price target upped by investment analysts at Credit Suisse Group from $115.00 to $122.00 in a research report issued on Wednesday. The brokerage currently has an “outperform” rating on the stock. Credit Suisse Group’s price objective indicates a potential upside of 20.60% from the stock’s current price.
HCA has been the topic of a number of other reports. Piper Jaffray Companies reissued a “buy” rating and issued a $92.00 price objective on shares of HCA Healthcare in a report on Wednesday, October 4th. Jefferies Group cut their price objective on HCA Healthcare from $90.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, November 1st. Wells Fargo & Co assumed coverage on HCA Healthcare in a report on Tuesday. They issued an “outperform” rating and a $116.00 price objective on the stock. SunTrust Banks set a $105.00 target price on HCA Healthcare and gave the stock a “buy” rating in a report on Thursday, December 21st. Finally, Mizuho reaffirmed a “buy” rating on shares of HCA Healthcare in a report on Friday, October 20th. Four analysts have rated the stock with a sell rating, five have issued a hold rating and eighteen have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $99.90.
Shares of HCA Healthcare (NYSE HCA) traded down $0.29 during mid-day trading on Wednesday, hitting $101.16. The stock had a trading volume of 3,730,000 shares, compared to its average volume of 2,350,000. The company has a quick ratio of 1.41, a current ratio of 1.68 and a debt-to-equity ratio of -6.46. The firm has a market capitalization of $36,540.00, a price-to-earnings ratio of 17.03, a PEG ratio of 1.27 and a beta of 0.55. HCA Healthcare has a fifty-two week low of $71.18 and a fifty-two week high of $106.84.
In other HCA Healthcare news, SVP Victor L. Campbell sold 8,000 shares of the stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $78.00, for a total transaction of $624,000.00. Following the transaction, the senior vice president now owns 127,275 shares in the company, valued at $9,927,450. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Joseph A. Sowell III sold 58,175 shares of the stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $95.00, for a total value of $5,526,625.00. Following the transaction, the senior vice president now owns 40,536 shares in the company, valued at approximately $3,850,920. The disclosure for this sale can be found here. Insiders have sold 78,725 shares of company stock worth $7,132,797 in the last quarter. 2.90% of the stock is currently owned by company insiders.
A number of hedge funds have recently modified their holdings of HCA. Atlantic Trust LLC purchased a new position in HCA Healthcare during the second quarter worth approximately $118,000. BB&T Investment Services Inc. purchased a new position in shares of HCA Healthcare in the second quarter valued at approximately $141,000. D.A. Davidson & CO. lifted its position in shares of HCA Healthcare by 37.7% in the second quarter. D.A. Davidson & CO. now owns 1,970 shares of the company’s stock valued at $171,000 after acquiring an additional 539 shares in the last quarter. Massey Quick Simon & CO. LLC purchased a new position in shares of HCA Healthcare in the third quarter valued at approximately $251,000. Finally, Parametrica Management Ltd purchased a new position in shares of HCA Healthcare in the third quarter valued at approximately $299,000. Institutional investors own 75.23% of the company’s stock.
About HCA Healthcare
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
